BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
BGM Group Ltd.
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jul 21, 2026
$8.97+0.32 (+3.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
BGM statistics
Financials through Sep 30, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | BGM | Industry median |
|---|---|---|
| Market Cap | $3.60B | $197.05M |
| Enterprise Value | $3.59B | $106.56M |
| PS Ratio | 94.92 | 3.93 |
| PB Ratio | 9.21 | 2.14 |
| P/TBV Ratio | 101.27 | 2.46 |
Enterprise value
| Measure | BGM | Industry median |
|---|---|---|
| EV / Sales | 94.68 | 2.69 |
Income (trailing twelve months)
| Measure | BGM | Industry median |
|---|---|---|
| Revenue | $37.92M | $57.94M |
| Gross Profit | $6.31M | $90.47M |
| Operating Income | -$12.58M | -$21.44M |
| Pretax Income | -$19.94M | -$14.45M |
| Net Income | -$19.94M | -$22.46M |
| EBITDA | -$11.12M | -$16.91M |
| EPS (Diluted) | -$0.18 | -$0.83 |
Margins
| Measure | BGM | Industry median |
|---|---|---|
| Gross Margin | 16.6% | 52.3% |
| Operating Margin | -33.2% | -44.5% |
| Pretax Margin | -52.6% | -13.0% |
| Profit Margin | -52.6% | -39.2% |
| EBITDA Margin | -29.3% | -31.3% |
| FCF Margin | -10.4% | -8.85% |
Returns
| Measure | BGM | Industry median |
|---|---|---|
| Return on Equity (ROE) | -9.20% | -53.1% |
| Return on Assets (ROA) | -8.19% | -41.0% |
| Return on Invested Capital (ROIC) | -4.80% | -32.0% |
| Return on Capital Employed (ROCE) | -3.21% | -37.8% |
Growth
| Measure | BGM | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 51.1% | 6.01% |
| FCF Growth (YoY) | -1395.3% | 2.34% |
| Revenue Growth (3Y CAGR) | -16.4% | 2.25% |
| Revenue Growth (5Y CAGR) | -5.39% | 6.42% |
Balance sheet
| Measure | BGM | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.82M | $62.42M |
| Net Cash (Debt) | $9.82M | $15.68M |
| Net Cash Per Share | $0.02 | $0.65 |
| Equity (Book Value) | $390.88M | $48.79M |
| Book Value Per Share | $0.97 | $1.36 |
| Tangible Book Value | $35.54M | $23.06M |
| Working Capital | $9.95M | $75.77M |
Financial position
| Measure | BGM | Industry median |
|---|---|---|
| Current Ratio | 1.24 | 3.30 |
| Quick Ratio | 0.34 | 2.39 |
Cash flow (trailing twelve months)
| Measure | BGM | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.37M | -$12.35M |
| Capital Expenditures | -$1.57M | -$1.06M |
| Free Cash Flow | -$3.94M | -$20.28M |
| FCF Per Share | -$0.01 | -$0.41 |
Efficiency
| Measure | BGM | Industry median |
|---|---|---|
| Asset Turnover | 0.16 | 0.38 |
| Inventory Turnover | 2.51 | 2.67 |
| Revenue Per Employee | $110.23K | $398.96K |
| Profits Per Employee | -$57.97K | -$732.08K |
| Employee Count | 344 | 73 |
Dividends and yields
| Measure | BGM | Industry median |
|---|---|---|
| Earnings Yield | -0.55% | -21.2% |
| FCF Yield | -0.11% | -7.64% |
Shares
| Measure | BGM | Industry median |
|---|---|---|
| Shares Outstanding | 401,247,000 | 59,128,900 |
| Shares Change (YoY) | 1467.3% | 11.1% |
| Float | 190,739,000 | 48,744,500 |
| Shares Held by Insiders | 52.5% | 11.8% |
Taxes
| Measure | BGM | Industry median |
|---|---|---|
| Income Tax | $277.79K | $91.50K |
Scores
| Measure | BGM | Industry median |
|---|---|---|
| Altman Z-Score | 51.49 | 0.10 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from BGM's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.